<?xml version="1.0" encoding="UTF-8"?>
<ref id="pntd.0007860.ref036">
 <label>36</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Laustsen</surname>
   <given-names>AH</given-names>
  </name>, 
  <name>
   <surname>Engmark</surname>
   <given-names>M</given-names>
  </name>, 
  <name>
   <surname>Milbo</surname>
   <given-names>C</given-names>
  </name>, 
  <name>
   <surname>Johannesen</surname>
   <given-names>J</given-names>
  </name>, 
  <name>
   <surname>Lomonte</surname>
   <given-names>B</given-names>
  </name>, 
  <name>
   <surname>Gutierrez</surname>
   <given-names>JM</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>From Fangs to Pharmacology: The Future of Snakebite Envenoming Therapy</article-title>. 
  <source>Curr Pharm Des</source>. 
  <year>2016</year>;
  <volume>22</volume>(
  <issue>34</issue>):
  <fpage>5270</fpage>â€“
  <lpage>93</lpage>. 
  <pub-id pub-id-type="doi">10.2174/1381612822666160623073438</pub-id> .
  <?supplied-pmid 27339430?>
  <pub-id pub-id-type="pmid">27339430</pub-id>
 </mixed-citation>
</ref>
